Progyny Reports Strong Q1 Results, Completes $200M Share Buyback, and Issues Positive 2026 Guidance
summarizeSummary
Progyny announced strong first-quarter 2026 financial results, including significant net income growth, and completed its $200 million share repurchase program, while also issuing positive guidance for the second quarter and full year 2026.
check_boxKey Events
-
Strong Q1 2026 Financial Performance
Progyny reported first-quarter 2026 revenue of $328.5 million, a 1.4% increase year-over-year (12.2% excluding a former large client). Net income significantly increased to $24.2 million, or $0.29 per diluted share, compared to $15.1 million, or $0.17 per diluted share, in the prior year period.
-
Completion of Share Repurchase Program
The company completed its November 2025 share repurchase program, having bought back 5.5 million shares for $116.4 million during Q1 2026. Cumulatively, 8.8 million shares were repurchased under the $200 million authorization, and the Board is now evaluating options for a new program.
-
Positive Q2 and Full Year 2026 Guidance
Progyny provided Q2 2026 revenue guidance of $342.0 million to $355.0 million and full-year 2026 revenue guidance of $1.365 billion to $1.405 billion. The company also projected full-year diluted EPS of $1.23 to $1.34 and Adjusted EBITDA of $232.0 million to $244.0 million.
auto_awesomeAnalysis
Progyny's first-quarter results demonstrate solid operational performance, with significant growth in net income and an expanded gross margin. The completion of the $200 million share repurchase program, with a substantial $116.4 million executed in Q1, signals a strong commitment to shareholder returns. The company's proactive evaluation of a new repurchase program further reinforces this positive capital allocation strategy. While Q2 revenue guidance was previously reported, the comprehensive full-year outlook and detailed Q1 results provide a clear picture of the company's financial health and future expectations, making this a strong positive signal for investors.
At the time of this filing, PGNY was trading at $21.86 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $16.10 to $28.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.